dehydroepiandrosterone sulfate has been researched along with fosfestrol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honda, M; Hosoya, Y; Kitahara, S; Koga, F; Moriguchi, H; Sumi, S; Umeda, H; Yano, M; Yoshida, K | 1 |
| Fukabori, Y; Kobayashi, M; Kosaku, N; Nakata, S; Takezawa, Y; Yamanaka, H | 1 |
2 other study(ies) available for dehydroepiandrosterone sulfate and fosfestrol
| Article | Year |
|---|---|
Effects of intravenous administration of high dose-diethylstilbestrol diphosphate on serum hormonal levels in patients with hormone-refractory prostate cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents; Chlormadinone Acetate; Dehydroepiandrosterone Sulfate; Diethylstilbestrol; Drug Resistance, Neoplasm; Estradiol; Follicle Stimulating Hormone; Goserelin; Hormones; Humans; Hydrocortisone; Leuprolide; Male; Middle Aged; Progesterone Congeners; Prostatic Neoplasms; Sex Hormone-Binding Globulin; Testosterone | 1999 |
Moderate dose diethylstilbestrol diphosphate therapy in hormone refractory prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Humans; Injections, Intravenous; Male; Middle Aged; Prostatic Neoplasms; Testosterone | 2001 |